Why do I have fatigue after treatment for Hodgkin lymphoma?

Question

Hello doctor,

I completed chemotherapy for Hodgkin lymphoma about one year ago using the ABVD regimen. Follow-up scans have been clear so far, but there is still significant anxiety before every follow-up visit. Fatigue is present on most days, and there is occasional heaviness in the chest, which raises concern about possible recurrence.

Additionally, hair has grown back thinner than before, and menstrual periods have become irregular. There is also awareness that cancer survivors may have a higher risk of developing heart or lung complications later due to chemotherapy drugs or radiation therapy.

Is it normal to experience persistent fatigue this long after completing treatment?
Could chemotherapy have caused long-term hormonal changes?
How frequently should cardiac and pulmonary evaluations be done?

I want to understand what is considered a normal part of recovery after treatment and which symptoms may require further medical evaluation.

Kindly advise.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

The condition you experienced is very common after treatment for Hodgkin lymphoma, both physically and emotionally.

It is very common for fatigue to last for several months or even a couple of years after chemotherapy. The ABVD regimen (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine) can cause lingering tiredness due to its effects on bone marrow, metabolism, and sometimes mild nerve or thyroid changes. Gradual improvement usually occurs with regular physical activity, balanced nutrition, and adequate sleep. However, persistent or worsening fatigue should be evaluated to rule out anemia, thyroid dysfunction, or depression.

Yes, the ABVD regimen can temporarily affect ovarian function. Irregular or absent menstrual periods are common after chemotherapy. In some women, menstrual cycles return to normal over time, while in others, early menopause may occur. A medical oncologist or gynecologist can evaluate hormone status by checking follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estrogen levels.

Certain chemotherapy drugs can affect long-term organ function. Doxorubicin may affect heart function, and Bleomycin can cause lung injury or scarring.

I suggest the following recommended monitoring:

An echocardiogram every one to two years to assess heart function.
A pulmonary function test should be performed if new or persistent shortness of breath develops.
Avoiding smoking and maintaining heart-healthy lifestyle habits are strongly advised.

Fear of cancer recurrence is very common among survivors. Routine follow-up visits and imaging studies every three to six months during the first few years after treatment are usually sufficient. Not every ache, symptom, or episode of fatigue indicates a relapse. Imaging and further evaluation are guided by symptoms and scheduled follow-ups.

Practices such as mindfulness, psychological counseling, or participation in cancer survivor support groups can be very helpful in managing follow-up–related anxiety, often referred to as scan-related anxiety.

The symptoms described are largely consistent with normal recovery after Hodgkin lymphoma treatment. However, it is reasonable to undergo annual thyroid function testing, an echocardiogram, and a general health evaluation. If chest heaviness persists or worsens, it should be reported promptly to a healthcare provider for reassurance and appropriate evaluation.

I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.

Thank you.